These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 25243574

  • 1. Effects of early thyroxine treatment on development and growth at age 10.7 years: follow-up of a randomized placebo-controlled trial in children with Down's syndrome.
    Marchal JP, Maurice-Stam H, Ikelaar NA, Klouwer FC, Verhorstert KW, Witteveen ME, Houtzager BA, Grootenhuis MA, van Trotsenburg AS.
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2722-9. PubMed ID: 25243574
    [Abstract] [Full Text] [Related]

  • 2. The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial.
    van Trotsenburg AS, Vulsma T, van Rozenburg-Marres SL, van Baar AL, Ridder JC, Heymans HS, Tijssen JG, de Vijlder JJ.
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3304-11. PubMed ID: 15755847
    [Abstract] [Full Text] [Related]

  • 3. L-thyroxine therapy and growth processes in children with Down syndrome.
    Kowalczyk K, Pukajło K, Malczewska A, Król-Chwastek A, Barg E.
    Adv Clin Exp Med; 2013 Jun; 22(1):85-92. PubMed ID: 23468266
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Thyroid dysfunction in HIV-infected children: is L-thyroxine therapy beneficial?
    Rana S, Nunlee-Bland G, Valyasevi R, Iqbal M.
    Pediatr AIDS HIV Infect; 1996 Dec; 7(6):424-8. PubMed ID: 11361500
    [Abstract] [Full Text] [Related]

  • 11. Early thyroxine treatment in Down syndrome and thyroid function later in life.
    Zwaveling-Soonawala N, Witteveen ME, Marchal JP, Klouwer FCC, Ikelaar NA, Smets AMJB, van Rijn RR, Endert E, Fliers E, van Trotsenburg ASP.
    Eur J Endocrinol; 2017 May; 176(5):505-513. PubMed ID: 28137734
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comorbidity, hospitalization, and medication use and their influence on mental and motor development of young infants with Down syndrome.
    van Trotsenburg AS, Heymans HS, Tijssen JG, de Vijlder JJ, Vulsma T.
    Pediatrics; 2006 Oct; 118(4):1633-9. PubMed ID: 17015556
    [Abstract] [Full Text] [Related]

  • 14. Capillary TSH screening programme for Down's syndrome in Scotland, 1997-2009.
    McGowan S, Jones J, Brown A, Reynolds L, Leyland K, Charleton P, Rahim M, Mansor M, Ritha S, Donaldson M, Scottish Down Syndrome Thyroid Screening Group.
    Arch Dis Child; 2011 Dec; 96(12):1113-7. PubMed ID: 21965810
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial.
    de la Torre R, de Sola S, Hernandez G, Farré M, Pujol J, Rodriguez J, Espadaler JM, Langohr K, Cuenca-Royo A, Principe A, Xicota L, Janel N, Catuara-Solarz S, Sanchez-Benavides G, Bléhaut H, Dueñas-Espín I, Del Hoyo L, Benejam B, Blanco-Hinojo L, Videla S, Fitó M, Delabar JM, Dierssen M, TESDAD study group.
    Lancet Neurol; 2016 Jul; 15(8):801-810. PubMed ID: 27302362
    [Abstract] [Full Text] [Related]

  • 16. Growth studies in infants and children with Down's syndrome and elevated levels of thyrotropin.
    Sharav T, Collins RM, Baab PJ.
    Am J Dis Child; 1988 Dec; 142(12):1302-6. PubMed ID: 2973745
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia.
    Chowdhry P, Scanlon JW, Auerbach R, Abbassi V.
    Pediatrics; 1984 Mar; 73(3):301-5. PubMed ID: 6366725
    [Abstract] [Full Text] [Related]

  • 19. Thyroid hormone and folinic acid in young children with Down syndrome: the phase 3 ACTHYF trial.
    Mircher C, Sacco S, Bouis C, Gallard J, Pichot A, Le Galloudec E, Cieuta C, Marey I, Greiner-Mahler O, Dorison N, Gambarini A, Stora S, Durand S, Polak M, Baruchel A, Schlumberger E, Dewailly J, Azar-Kolakez A, Guéant-Rodriguez RM, Guéant JL, Borderie D, Bonnefont-Rousselot D, Blondiaux E, Ravel A, Sturtz FG.
    Genet Med; 2020 Jan; 22(1):44-52. PubMed ID: 31281181
    [Abstract] [Full Text] [Related]

  • 20. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W, Spieker K, Weike AI, Giessmann T, Modess C, Dabers T, Kirsch G, Sänger E, Engel G, Hamm AO, Nauck M, Meng W.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.